Abrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017.

Na, Tao

Abrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017. [electronic resource] - Acta pharmacologica Sinica Jun 2007 - 773-82 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1671-4083

10.1111/j.1745-7254.2007.00580.x doi


Animals
Anti-Arrhythmia Agents--chemistry
Aspartic Acid Endopeptidases--genetics
Berberine--analogs & derivatives
Calcium--metabolism
Cardiomyopathies--chemically induced
Cyclic AMP-Dependent Protein Kinases--metabolism
Endothelin-Converting Enzymes
Heart--drug effects
Humans
Metalloendopeptidases--genetics
Molecular Structure
Myocytes, Cardiac--cytology
Nitric Oxide Synthase Type II--genetics
Rats
Reperfusion
Sarcoplasmic Reticulum Calcium-Transporting ATPases--metabolism
Tacrolimus Binding Proteins--metabolism
Thyroxine--adverse effects
Ventricular Fibrillation--metabolism